Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2012
09/13/2012CA2832377A1 New pyridazinone and pyridone compounds
09/13/2012CA2830706A1 Quinolinone derivatives
09/13/2012CA2829801A1 Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid
09/13/2012CA2829322A1 Androgen receptor antagonists and uses thereof
09/13/2012CA2829187A1 Dipyridylamine derivative
09/13/2012CA2829086A1 Heavy-duty vehicle brake assembly with sealing interface
09/13/2012CA2828999A1 Primary amine diazeniumdiolate heterocyclic derivatives
09/13/2012CA2828578A1 Mst1 kinase inhibitors and methods of their use
09/13/2012CA2828337A1 Fluoro-pyridinone derivatives useful as antibacterial agents
09/12/2012EP2497768A2 Novel 2, 4-pyrimidine derivatives and use thereof
09/12/2012EP2496569A2 Heterocyclic derivatives
09/12/2012EP2496568A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof
09/12/2012EP2496559A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
09/12/2012EP2496558A1 Thetrahydroquinolines derivatives as bromodomain inhibitors
09/12/2012EP2496557A1 Tetrahydroquinoline derivatives and their pharmaceutical use
09/12/2012EP2496234A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/12/2012CN102666537A Azaindazoles to treat flaviviridae virus infection
09/12/2012CN102666531A Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/12/2012CN102666526A Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
09/12/2012CN102666525A Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof
09/12/2012CN102666500A Seven-membered ring compound and pharmaceutical use therefor
09/12/2012CN102666495A Potassium channel modulators
09/12/2012CN102666491A Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
09/12/2012CN102666490A Aminopyridine compound
09/12/2012CN102666489A Sphingosine kinase inhibitors
09/12/2012CN102666485A Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
09/12/2012CN102659774A Piperidine and piperazine derivatives as P2X3 antagonists
09/12/2012CN102659763A Method for synthesizing and purifying dexlansoprazole
09/12/2012CN102659762A Crystal form of imatinib mesylate and preparation method thereof
09/12/2012CN102659761A Method for preparing besifloxacin hydrochloride
09/12/2012CN102659760A Extraction technology of nicotine by acid process
09/12/2012CN102659759A Lomefloxacin aspartate hydrate and its novel preparation method and use
09/12/2012CN102659708A Structure and preparation method for heterocyclic aryl acetylene compounds containing benzoxazole and benzothiazole groups
09/12/2012CN102659494A Method for asymmetric synthesis of 3,3-disubstituted-2-oxindole compound
09/12/2012CN101941941B Carboxylic ester compound and applications thereof
09/12/2012CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase
09/12/2012CN101048401B Pyrimidine sulphonamide derivatives as chemokine receptor modulators
09/11/2012US8263782 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
09/11/2012US8263765 Pyrrolotriazine kinase inhibitors
09/11/2012US8263632 Aminopyridine derivatives having Aurora A selective inhibitory action
09/11/2012US8263624 Aryl-substituted heterocycles, and use thereof
09/11/2012US8263605 Modulators of muscarinic receptors
09/11/2012US8263604 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
09/11/2012US8263597 Indazole compounds as CCR1 receptor antagonists
09/11/2012US8263590 Pyrimidine derivatives
09/11/2012US8263588 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/11/2012US8263238 Ambipolar host in organic light emitting diode
09/11/2012CA2673988C Stable s-nitrosothiols, method of synthesis and use
09/11/2012CA2558506C Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
09/11/2012CA2543351C Amide derivatives
09/11/2012CA2513555C Process for the preparation of pyridylsulfinylbenzimidazoles
09/11/2012CA2445159C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
09/08/2012CA2825519A1 Pyrrole derivatives used as modulators of alpha7 nachr
09/07/2012WO2012119046A2 Heterocyclic compounds for the inhibition of pask
09/07/2012WO2012119006A2 Derivatives of pyrazole-substituted amino-heteroaryl compounds
09/07/2012WO2012118812A2 Substituted 6,5-fused bicyclic heteroaryl compounds
09/07/2012WO2012118563A2 6-alkyl-n-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
09/07/2012WO2012118309A2 Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same
09/07/2012WO2012117996A1 Gpr119 agonist
09/07/2012WO2012117421A1 Histone deacetylase inhibitors
09/07/2012WO2012117224A1 Dipyridinium derivatives
09/07/2012WO2012117216A1 N- (arylalkyl) - 1h- indole- 2 - sulfonic acid amide compounds and their therapeutic use as cannabinoid allosteric modulators
09/07/2012WO2012117021A2 Novel microbiocidal oxime ethers
09/07/2012WO2012117000A1 3-amino-pyridines as gpbar1 agonists
09/07/2012WO2012116666A1 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof
09/07/2012WO2012116440A1 Benzimidazole inhibitors of the sodium channel
09/07/2012WO2012116415A1 Novel small-molecules as therapeutics
09/07/2012WO2012080284A3 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
09/07/2012WO2012035421A3 Pyridine compounds and the uses thereof
09/07/2012CA2829025A1 Derivatives of pyrazole-substituted amino-heteroaryl compounds
09/07/2012CA2828877A1 6-alkyl-n-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
09/07/2012CA2828780A1 Novel small-molecules as therapeutics
09/07/2012CA2828636A1 Dipyridinium derivatives
09/07/2012CA2828456A1 Benzimidazole inhibitors of the sodium channel
09/07/2012CA2828349A1 Heterocyclic compounds for the inhibition of pask
09/07/2012CA2827718A1 3-amino-pyridines as gpbar1 agonists
09/07/2012CA2820709A1 Substituted quinoline compounds and methods of use
09/06/2012US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
09/06/2012US20120226039 N-Phenyl-2-pyrimidine-amine Derivatives
09/06/2012US20120226038 Crystal Form H of Imatinib Mesylate for Pharmaceutical Use
09/06/2012US20120226036 Substituted carbonyl compound
09/06/2012US20120226033 4-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases
09/06/2012US20120225910 Substituted Heteroaryls
09/06/2012US20120225909 Indazole analog
09/06/2012US20120225907 Benzamide compounds useful as histone deacetylase inhibitors
09/06/2012US20120225896 Novel 2-pyridone derivative and pharmaceutical product containing same
09/06/2012US20120225892 [1,5]-Diazocin Derivatives
09/06/2012US20120225891 Amide derivatives, process for preparation thereof and use thereof as insecticide
09/06/2012US20120225886 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
09/06/2012US20120225880 Pyrazole compounds and thiazole compounds as protein kinases inhibitors
09/06/2012US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/06/2012US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/06/2012US20120225874 Bicyclic derivatives as cetp inhibitors
09/06/2012US20120225873 Compounds for alzheimer's disease
09/06/2012US20120225872 Methods of preparing and using quinazoline and quinoline derivatives
09/06/2012US20120225871 Small-molecule modulators of trp-p8 activity
09/06/2012US20120225867 Androgen receptor modulating compounds
09/06/2012US20120225862 Heteroaryl benzamides, compositions and methods of use
09/06/2012US20120225857 Mst1 kinase inhibitors and methods of their use
09/06/2012US20120225854 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 1080